Complementary Neurosteroid Intervention in Gulf War Illnesses (GWVI)

PHASE2CompletedINTERVENTIONAL
Enrollment

170

Participants

Timeline

Start Date

October 1, 2013

Primary Completion Date

October 10, 2018

Study Completion Date

October 10, 2018

Conditions
FatigueMusculoskeletal PainCognitive Decline
Interventions
DRUG

Pregnenolone

Pregnenolone 50mg BID x 14 days, followed by Pregnenolone 150 x 14 days, followed by Pregnenolone 250 mg BID x 28 days

DRUG

Placebo

Placebo 50mg BID x 14 days, followed by Placebo 150 x 14 days, followed by Placebo 250 mg BID x 28 days

Trial Locations (1)

27705

Durham VA Medical Center, Durham, NC, Durham

All Listed Sponsors
lead

VA Office of Research and Development

FED

NCT01956279 - Complementary Neurosteroid Intervention in Gulf War Illnesses (GWVI) | Biotech Hunter | Biotech Hunter